3 Best Performing ASX shares in week 48, 6 December 2021

Marc Kennis Marc Kennis, December 13, 2021

Best performing ASX shares: Two of the three best performing ASX stocks are (ex) Marc & Stuart’s Top Picks: Neuren Pharmaceuticals (ASX:NEU) was up 117.5% and Revasum (ASX:RVS) went up 39.8%. Sky Network Television (ASX:SKT) rose 36.5% last week and completed the Top 3 Best performing ASX shares.

 

1. Neuren Pharmaceuticals (ASX: NEU)

Industry: Healthcare

Neuren Pharmaceuticals (ASX: NEU) is an ex-Top Pick on which we made more than 78% earlier this year. It is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders. It has two key drug products comprising NNZ-2566 and NNZ-2591 and has operations in New Zealand, Australia and the USA.

Market Cap: $485M

12 month high / low: $4.04 – $1.20

 

Neuren Pharmaceuticals

 

 

2. Revasum (ASX:RVS)

Industry: Technology

Revasum (ASX:RVS) is a current Top Pick. The company specialises in the design and manufacturing of equipment used to build semiconductors, specifically grinders and polishers for Silicon Carbide (SiC) wafers. SiC chips are used in high voltage applications, like Electric Vehicles and Solar. Revasum’s technology and equipment assists in the advancement of technology for a range of markets and applications including automotive, IoT, 5G, telecommunications, electrification and power devices.

Market Cap: $76M

12 month high / low: $0.88 – $0.21

 

Revasum

 

 

3. Sky Network Television (ASX:SKT)

Industry: Consumer

Sky Network Television (ASX:SKT) is a New Zealand broadcasting company that provides pay television services via satellite, media streaming services and broadband internet services. It is also a wholesale channel provider to New Zealand IPTV provider Vodafone.

Market Cap: $405M

12 month high / low: $2.32 – $1.40

 

Sky Network Television

 

 

Learn more about ASX-listed stocks with
Stocks Down Under!

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

 

Recent Posts

Transition Resources

New thinking helps 2025 ASX IPO candidate Transition Resources make new discoveries in Cloncurry

Humble beginnings The resources industry in Australia attracts people with a diverse array of backgrounds, and David Wilson, Managing Director…

4D Medical

4D Medical (ASX:4DX) could become the next Pro Medicus, it’s a long way to the top

There’s not many Australian radiology companies that seek to conquer the USA, but 4D Medical (ASX:4DX) is one of them.…

signs to buy a stock

Pay attention to these 5 signs to buy a stock

What are the most important signs to buy a stock on the ASX or any other stock exchange? In this…